Chronic Obstructive Pulmonary Disease in Patients Who Have HIV Infection

Clinics in Chest Medicine

Volumn 28, Issue 3, 2007, Pages 575-587

  Crothers, Kristina ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE;

ASTHMA; BACTERIAL PNEUMONIA; BRONCHUS HYPERREACTIVITY; CD8+ T LYMPHOCYTE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DRUG ABUSE; EXERCISE; FORCED EXPIRATORY VOLUME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG EMPHYSEMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SMOKING CESSATION; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SURVIVAL RATE; WORLD HEALTH;

EID: 34548046488     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2007.06.004     Document Type: Review

References (80)

1. 2006 Update: global strategy for the diagnosis, management, and prevention of COPD. Available at: www.goldcopd.com. Accessed May 31, 2007.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 24 1997;349(9064):1498-1504.
3. Mannino D.M., Homa D.M., Akinbami L.J., et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51 6 (2002) 1-16
4. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121 Suppl 5 (2002) 121S-126S
5. Sandford A.J., and Silverman E.K. Chronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interaction. Thorax 57 8 (2002) 736-741
6. Chapman K.R. Chronic obstructive pulmonary disease: are women more susceptible than men?. Clin Chest Med 25 2 (2004) 331-341
7. Silverman E.K., Weiss S.T., Drazen J.M., et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 6 (2000) 2152-2158
8. Petty T.L., and Weinmann G.G. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National heart, lung, and blood institute workshop summary. Bethesda, Maryland, August 29-31, 1995. JAMA 277 3 (1997) 246-253
9. Diaz P.T., King M.A., Pacht E.R., et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 132 5 (2000) 369-372
10. Guillemi S.A., Staples C.A., Hogg J.C., et al. Unexpected lung lesions in high resolution computed tomography (HRTC) among patients with advanced HIV disease. Eur Respir J 9 1 (1996) 33-36
11. Kuhlman J.E., Knowles M.C., Fishman E.K., et al. Premature bullous pulmonary damage in AIDS: CT diagnosis. Radiology 173 1 (1989) 23-26
12. Diaz P.T., Wewers M.D., Pacht E., et al. Respiratory symptoms among HIV-seropositive individuals. Chest 123 6 (2003) 1977-1982
13. Poirier C.D., Inhaber N., Lalonde R.G., et al. Prevalence of bronchial hyperresponsiveness among HIV-infected men. Am J Respir Crit Care Med 164 4 (2001) 542-545
14. O'Donnell C.R., Bader M.B., Zibrak J.D., et al. Abnormal airway function in individuals with the acquired immunodeficiency syndrome. Chest 94 5 (1988) 945-948
15. McGuinness G., Naidich D.P., Garay S., et al. AIDS associated bronchiectasis: CT features. J Comput Assist Tomogr 17 2 (1993) 260-266
16. Bard M., Couderc L.J., Saimot A.G., et al. Accelerated obstructive pulmonary disease in HIV infected patients with bronchiectasis. Eur Respir J 11 3 (1998) 771-775
17. Diaz P.T., King M.A., Pacht E.R., et al. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am J Respir Crit Care Med 160 1 (1999) 272-277
18. Crothers K., Butt A.A., Gibert C.L., et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 130 5 (2006) 1326-1333
19. Gelman M., King M.A., Neal D.E., et al. Focal air trapping in patients with HIV infection: CT evaluation and correlation with pulmonary function test results. AJR Am J Roentgenol 172 4 (1999) 1033-1038
20. King M.A., Neal D.E., St John R., et al. Bronchial dilatation in patients with HIV infection: CT assessment and correlation with pulmonary function tests and findings at bronchoalveolar lavage. AJR Am J Roentgenol 168 6 (1997) 1535-1540
21. Wallace J.M., Stone G.S., Browdy B.L., et al. Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary complications of HIV infection study group. Chest 111 1 (1997) 121-127
22. Tashkin D.P., Altose M.D., Connett J.E., et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The lung health study research group. Am J Respir Crit Care Med 153 6 Pt 1 (1996) 1802-1811
23. Niaura R., Shadel W.G., Morrow K., et al. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 31 3 (2000) 808-812
24. Gritz E.R., Vidrine D.J., Lazev A.B., et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 6 1 (2004) 71-77
25. Page-Shafer K., Delorenze G.N., Satariano W.A., et al. Comorbidity and survival in HIV-infected men in the San Francisco men's health survey. Ann Epidemiol 6 5 (1996) 420-430
26. Galai N., Park L.P., Wesch J., et al. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 14 5 (1997) 451-458
27. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2004. MMWR Morb Mortal Wkly Rep 54 44 (2005) 1121-1124
28. Justice A.C., Dombrowski E., Conigliaro J., et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care 44 8 Suppl 2 (2006) S13-S24
29. Wolff A.J., and O'Donnell A.E. Pulmonary effects of illicit drug use. Clin Chest Med 25 1 (2004) 203-216
30. Haim D.Y., Lippmann M.L., Goldberg S.K., et al. The pulmonary complications of crack cocaine. A comprehensive review. Chest 107 1 (1995) 233-240
31. Moore B.A., Augustson E.M., Moser R.P., et al. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med 20 1 (2005) 33-37
32. Tashkin D.P. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med 7 2 (2001) 43-61
33. Tetrault J.M., Crothers K., Moore B.A., et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 167 3 (2007) 221-228
34. Cohen B.H., Celentano D.D., Chase G.A., et al. Alcohol consumption and airway obstruction. Am Rev Respir Dis 121 2 (1980) 205-215
35. Lange P., Groth S., Mortensen J., et al. Pulmonary function is influenced by heavy alcohol consumption. Am Rev Respir Dis 137 5 (1988) 1119-1123
36. Balmes J., Becklake M., Blanc P., et al. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 167 5 (2003) 787-797
37. Prescott E., and Vestbo J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 54 8 (1999) 737-741
38. Chen Y., Breithaupt K., and Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 53 7 (2000) 755-761
39. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 117 5 Suppl 1 (2000) 286S-291S
40. Hogg J.C. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 164 10 Pt 2 (2001) S71-S75
41. Morris A., Sciurba F.C., Lebedeva I.P., et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 170 4 (2004) 408-413
42. Morris A.M., Huang L., Bacchetti P., et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 612-616
43. Wang Z., Zheng T., Zhu Z., et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192 11 (2000) 1587-1600
44. Saetta M., Baraldo S., Corbino L., et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 2 (1999) 711-717
45. Twigg III H.L., Spain B.A., Soliman D.M., et al. Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 276 2 Pt 1 (1999) L256-L262
46. Twigg H.L., Soliman D.M., Day R.B., et al. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 159 5 Pt 1 (1999) 1439-1444
47. Hogg J.C., and Hegele R.G. Adenovirus and Epstein-Barr virus in lung disease. Semin Respir Infect 10 4 (1995) 244-253
48. Seemungal T., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 9 (2001) 1618-1623
49. Wilkinson T.M., Patel I.S., Wilks M., et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 8 (2003) 1090-1095
50. Calderon E., de la Horra C., Medrano F.J., et al. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis 23 7 (2004) 545-549
51. Morris A., Kingsley L.A., Groner G., et al. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 18 5 (2004) 793-798
52. MacNee W. Oxidants/antioxidants and COPD. Chest 117 5 Suppl 1 (2000) 303S-317S
53. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 1 (2005) 50-60
54. Treitinger A., Spada C., Verdi J.C., et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest 30 5 (2000) 454-459
55. Buhl R. Imbalance between oxidants and antioxidants in the lungs of HIV-seropositive individuals. Chem Biol Interact 91 2-3 (1994) 147-158
56. Revillard J.P., Vincent C.M., Favier A.E., et al. Lipid peroxidation in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 5 6 (1992) 637-638
57. Pacht E.R., Diaz P., Clanton T., et al. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. Chest 112 3 (1997) 785-788
58. Braithwaite R.S., Justice A.C., Chang C.C., et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 118 8 (2005) 890-898
59. Krentz H.B., Kliewer G., and Gill M.J. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 6 2 (2005) 99-106
60. Crum N.F., Riffenburgh R.H., Wegner S., et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 41 2 (2006) 194-200
61. Crothers K., Justice A.C., Rimland D., et al. Increased infectious and non-infectious pulmonary diseases among HIV positive compared to HIV negative veterans. Proc Am Thorac Soc 3 (2006) A477
62. Wallace J.M., Hansen N.I., Lavange L., et al. Respiratory disease trends in the pulmonary complications of HIV infection study cohort. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 155 1 (1997) 72-80
63. Crothers K., Griffith T.A., McGinnis K.A., et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 20 12 (2005) 1142-1145
64. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 6 (2004) 932-946
65. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 8 (2007) 775-789
66. Crothers K., Goulet J.L., Rodriguez-Barradas M.C., et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 22 6 (2007) 749-754
67. Cummins D., Trotter G., Moussa M., et al. Smoking cessation for clients who are HIV-positive. Nurs Stand 20 12 (2005) 41-47
68. Vidrine D.J., Arduino R.C., Lazev A.B., et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 20 2 (2006) 253-260
69. Wewers M.E., Neidig J.L., and Kihm K.E. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care 11 6 (2000) 37-44
70. An L.C., Zhu S.H., Nelson D.B., et al. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med 166 5 (2006) 536-542
71. Oursler K.K., Goulet J.L., Leaf D.A., et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 20 11 (2006) 782-791
72. Nici L., Donner C., Wouters E., et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173 12 (2006) 1390-1413
73. Authier F.J., Chariot P., and Gherardi R.K. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 32 3 (2005) 247-260
74. Oursler K.K., Sorkin J.D., Smith B.A., et al. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses 22 11 (2006) 1113-1121
75. Schulz L., Nagaraja H.N., Rague N., et al. Respiratory muscle dysfunction associated with human immunodeficiency virus infection. Am J Respir Crit Care Med 155 3 (1997) 1080-1084
76. Nixon S., O'Brien K., Glazier R.H., and Tynan A.M. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev 2 (2005) CD001796
77. O'Brien K., Nixon S., Glazier R.H., and Tynan A.M. Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev 4 (2004) CD004248
78. Coultas D.B., Mapel D., Gagnon R., et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 164 3 (2001) 372-377
79. Sin D.D., McAlister F.A., Man S.F., et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 290 17 (2003) 2301-2312
80. Tomas L.H., and Varkey B. Improving health-related quality of life in chronic obstructive pulmonary disease. Curr Opin Pulm Med 10 2 (2004) 120-127